Solvay Pharmaceuticals News
Most Popular Solvay Pharmaceuticals Story
Abbott split creates an $18B biopharma deal-maker with deep pockets
Abbott Labs's decision to separate into two distinct companies will create a research-based pharma and biologics operation with $18 billion in revenue, a lineup of marketed drugs led by Humira and a Read more...
Latest Headlines
- December 19, 2011
- February 4, 2010
- September 28, 2009
- September 25, 2009
- September 24, 2009
- September 18, 2009
- July 30, 2009
- July 15, 2009
- November 17, 2008
- July 9, 2008
- June 3, 2008
- April 16, 2008
- February 29, 2008
- September 14, 2007
- August 30, 2007
- August 27, 2007
- August 13, 2007
- January 30, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
